India flags Abhayrab rabies vaccine batch as substandard
HYDERABAD — India’s drug regulator has flagged a batch of widely used rabies vaccine Abhayrab as substandard and potentially spurious after it failed a potency test, a government document seen by Reuters shows. The finding marks the second time in less than two years that concerns have been raised about counterfeit Abhayrab doses in India, a country that reports nearly 6,000 rabie
See all — The Manila Times →Aggregated from the leading newsrooms of the country. Every story links to its original source.







